PROCEPT BioRobotics (PRCT) Receivables (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Receivables for 7 consecutive years, with $107.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables rose 33.15% year-over-year to $107.6 million in Q2 2026; TTM through Jun 2026 was $107.6 million, a 33.15% increase from a year earlier, with the FY2025 full-year figure at $83.5 million, changed 0.04% from the prior year.
• Receivables was $107.6 million for Q2 2026 at PROCEPT BioRobotics, up from $96.4 million in the prior quarter.
• Over five years, Receivables peaked at $107.6 million in Q2 2026 and troughed at $7.0 million in Q1 2022.
• A 5-year average of $54.6 million and a median of $57.5 million in 2024 frame the typical range for Receivables.
• Across the five-year window, Receivables jumped 242.11% in 2022 and grew 0.04% in 2025, its largest moves.
• Over 5 years, Receivables stood at $15.3 million in 2022, then soared by 216.76% to $48.4 million in 2023, then surged by 72.6% to $83.5 million in 2024, then advanced by 0.04% to $83.5 million in 2025, then rose by 28.82% to $107.6 million in 2026.
• The last three Receivables figures came in at $107.6 million (Q2 2026), $96.4 million (Q1 2026), and $83.5 million (Q4 2025), per Business Quant data.